Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.
about
An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluationDisappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy.Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific AntibodiesBanff 2011 Meeting report: new concepts in antibody-mediated rejectionThe clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.Acute transplant glomerulopathy with monocyte rich infiltrate.Clinical role of the renal transplant biopsy.Phenotypes of antibody-mediated rejection in organ transplants.The specificity of acute and chronic microvascular alterations in renal allografts.Meta-analysis of observational studies: hepatitis C and survival after renal transplant.Transplant glomerulopathy: the interaction of HLA antibodies and endotheliumHepatitis C virus infection and kidney transplantation in 2014: what's new?Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.Hepatitis C and its impact on renal transplantation.Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomesCurrent pathological perspectives on chronic rejection in renal allografts.Hepatitis C Virus Infection in Chronic Kidney Disease.Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease.Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents.Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.De Novo Fibrillary Glomerulonephritis (FGN) in a Renal Transplant with Chronic Hepatitis C.Late kidney dysfunction in a kidney transplant recipientDirect-Acting Antivirals in Kidney Transplant Patients: Successful Hepatitis C Treatment and Short-Term Reduction in Urinary Protein/Creatinine Ratios.Transplant glomerulopathy: the view from the other side of the basement membrane.Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus-Associated Membranoproliferative Glomerulonephritis.Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM).Kidney allograft survival after acute rejection, the value of follow-up biopsies.Morphologic Features and Clinical Impact of Arteritis Concurrent with Transplant Glomerulopathy.Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial.Transplant glomerulopathy.Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants.Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.Thrombotic microangiopathy after renal transplantation: Current insights in and recurrent diseaseHepatitis C and renal transplantation in era of new antiviral agentsPrecision Diagnostics in Transplantation: From Bench to Bedside
P2860
Q33414342-363D35E5-9B87-4B25-8575-A2E37B511CF6Q34423734-2B3C16E9-D000-4B61-B6BA-0EB49D0C75C9Q35790585-964CC4C3-11DB-4F9A-AEF8-71C38F491E6BQ36746647-5C8CEB8A-BC5A-40B5-941B-C29240B2CBF8Q37052024-AD876D1B-2F8F-4922-A2D3-61424BA5CD2DQ37058043-2142D337-845F-47BC-82F2-3C1AB6F841A9Q37359074-E39C1766-B2D4-41EF-974E-490E11EBFD9CQ37387510-02E2D91E-9159-41CA-B340-B121685F66ECQ37974480-2699D7AE-E438-4722-8A23-0E1FB775629BQ38005448-C813DC29-3DE3-4E5D-A857-05C99FB9C5E2Q38151921-6E2C04D7-1B93-46DF-8486-27F0033005D6Q38203314-281E8FCD-9410-4E51-98F4-5DBB6F0855E6Q38205229-41A40F21-6A90-4B0B-A8CC-97895675D761Q38236820-FBDA8B6A-3E68-4356-A041-8BA2BB703390Q38282840-EB0A206C-1F09-4792-9B8D-254483BD0C8EQ38341218-8E8AF1C1-9FA7-4C12-A124-757FC1D6484FQ38602837-2334FAD5-1681-412E-BBC5-119F7EF242D2Q38795065-79342864-32DA-498C-8FC7-EDB8C180A5F4Q38812607-0D57C0DF-AE04-43F7-84C5-FCD242E40EE6Q39455853-9501DADC-9CC0-4C59-9EC5-7D8BE1B4E75DQ40278284-ADD20802-E5C2-4DA1-9344-923E88A22834Q40278746-FE549DBC-C25E-4039-A80A-161A25A19EAFQ41446409-5729C859-0915-4A6D-B227-8171D44A3FC1Q41834576-72CB85B9-204D-48B2-BA67-5F4AFB943EB3Q42640856-2A3C660A-B4E7-4A92-8CEC-ED02BB2194C3Q42943160-7143300B-0A9A-4609-9AED-4244F93DEB73Q45332478-9031D0A7-CE0F-401D-89C9-8DEF6F4B5B94Q45898843-C98DB1A9-09C9-4949-8BD4-CF973F3346EFQ46211382-DAE9DB42-3934-4E28-9C41-D700AB374B88Q46335702-7AEC437E-CE24-406A-BB4F-A234B07F2BBFQ47920746-04C9106C-39A7-43F3-9539-C049FEB763A7Q50063069-1F05794A-F55D-4C03-882F-90306CB84C18Q52890132-98722C70-3243-4312-A72C-0DC30216FC98Q53363804-192624F5-4BBB-44EC-893B-67EF7E35A866Q58754943-740A62FD-F9BB-429A-BCEF-1ACCE2672B98Q58792851-CF18D55E-F71A-46BC-AE30-1A99574EB3DDQ59314345-264D2B2D-D53F-422F-BF67-16673211ED8C
P2860
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Overlapping pathways to transp ...... nd thrombotic microangiopathy.
@ast
Overlapping pathways to transp ...... nd thrombotic microangiopathy.
@en
type
label
Overlapping pathways to transp ...... nd thrombotic microangiopathy.
@ast
Overlapping pathways to transp ...... nd thrombotic microangiopathy.
@en
prefLabel
Overlapping pathways to transp ...... nd thrombotic microangiopathy.
@ast
Overlapping pathways to transp ...... nd thrombotic microangiopathy.
@en
P2093
P356
P1433
P1476
Overlapping pathways to transp ...... nd thrombotic microangiopathy.
@en
P2093
A Bernard Collins
Manuel Pascual
Mary Lin Farrell
Nina Tolkoff-Rubin
Robert B Colvin
Seema Baid-Agrawal
Shamila Mauiyyedi
Ulrich Frei
P2888
P304
P356
10.1038/KI.2011.194
P407
P577
2011-06-22T00:00:00Z
P6179
1002474494